Press Releases about ABVC BioPharma, Inc. - Common Stock![]() ![]() ![]() ![]() ![]()
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
February 12, 2024
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via NewMediaWire
![]() ![]()
ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)
October 09, 2023
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]() ![]() ![]() ![]() ![]()
ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales
August 01, 2023
Via NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
Via NewMediaWire
![]() Via NewMediaWire
Topics
Regulatory Compliance
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|